Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Chemotherapy-Related Leukemia: early-phase trial registry

1 of 1 indexed Chemotherapy-Related Leukemia trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Chemotherapy-Related Leukemia: 1 US clinical trial tracked, 1 recruiting.

Chemotherapy-Related Leukemia is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 1 of these trials.

Enrollment posture brief

Registry condition chemotherapy-related-leukemia

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Chemotherapy-Related Leu (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Chemotherapy-Related Leukemia

Chemotherapy-Related Leukemia lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Chemotherapy-Related Leukemia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Chemotherapy-Related Leukemia is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Chemotherapy-Related Leukemia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Allogeneic Natural Killer Cell Line NK-92 Biological
1 trials
Clofarabine Drug
1 trials
Anti-Thymocyte Globulin Biological
1 trials
Busulfan Drug
1 trials
Cyclophosphamide Drug
1 trials

US sites by state

Facility locations filed on Chemotherapy-Related Leukemia trials. A trial with sites in several states counts in each.

Texas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Chemotherapy-Related Leukemia page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chemotherapy-Related Leukemia condition card totals 1 registered trials; most-linked intervention Allogeneic Natural Killer Cell Line NK-92; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.